pythium insidiosum colitis in a dog: treatment and clinical outcome

Clicks: 195
ID: 215603
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #295 of 436 articles by views in Trials

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 436 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
ABSTRACT: The aim of this report is to describe the clinical, pathological and imaging findings and treatment of colitis caused by Pythium insidiosum in a canine presenting haematochezia and progressive weight loss. Through imaging, a thickening of the transverse and descending colon was observed. Histopathological analysis of the large intestine fragment revealed the presence of hyphae, confirmed by immunohistochemistry and PCR as P. insidiosum. Antifungal treatment with itraconazole implemented after partial surgical resection, resulted in control of the disease.
Reference Key
fujimori2016cinciapythium Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Mahyumi Fujimori;Erika Rondon Lopes;Samara Rosolem Lima;Daphine Ariadne Jesus de Paula;Arleana do Bom Parto Ferreira de Almeida;Edson Moleta Colodel;Caroline Argenta Pescador;Pedro Eduardo Brandini Néspoli;Luciano Nakazato;Valéria Dutra;Roberto Lopes de Souza;Valéria Régia Franco Sousa
Journal Trials
Year 2016
DOI
10.1590/0103-8478cr20150081
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.